These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 25862012)

  • 1. Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol.
    Song IH; Borland J; Chen S; Wajima T; Peppercorn AF; Piscitelli SC
    Ann Pharmacother; 2015 Jul; 49(7):784-9. PubMed ID: 25862012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women.
    Zhang J; Chung E; Yones C; Persson A; Mahnke L; Eley T; Xu X; Bertz R
    Antivir Ther; 2011; 16(2):157-64. PubMed ID: 21447864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women.
    Sevinsky H; Eley T; Persson A; Garner D; Yones C; Nettles R; Krantz K; Bertz R; Zhang J
    Antivir Ther; 2011; 16(2):149-56. PubMed ID: 21447863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of laropiprant, a PGD2 receptor 1 antagonist, on estradiol and norgestimate pharmacokinetics after oral contraceptive administration in women.
    Schwartz JI; Liu F; Wang YH; Pramanik B; Johnson-Levonas AO; Gutierrez MJ; Lai E; Wagner JA
    Am J Ther; 2009; 16(6):487-95. PubMed ID: 19940609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of a clinically important pharmacokinetic interaction between sofosbuvir or ledipasvir and hormonal oral contraceptives norgestimate/ethinyl estradiol in HCV-uninfected female subjects.
    German P; Moorehead L; Pang P; Vimal M; Mathias A
    J Clin Pharmacol; 2014 Nov; 54(11):1290-8. PubMed ID: 24925712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol.
    Creinin MD; Lippman JS; Eder SE; Godwin AJ; Olson W
    Contraception; 2002 Sep; 66(3):147-52. PubMed ID: 12384201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multi-Center, Open-Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females.
    Xu Y; Gabriel K; Wang Y; Zhou Y; Eisele O; Vutikullird A; Mikol DD; Lee E
    CNS Drugs; 2019 May; 33(5):513-522. PubMed ID: 30963506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of effect of oral rifaximin on the pharmacokinetics of ethinyl estradiol/norgestimate in healthy females.
    Trapnell CB; Connolly M; Pentikis H; Forbes WP; Bettenhausen DK
    Ann Pharmacother; 2007 Feb; 41(2):222-8. PubMed ID: 17284510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the coadministration of daclatasvir on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate.
    Bifano M; Sevinsky H; Hwang C; Kandoussi H; Jiang H; Grasela D; Bertz R
    Antivir Ther; 2014; 19(5):511-9. PubMed ID: 24343001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of raltegravir on estradiol and norgestimate plasma pharmacokinetics following oral contraceptive administration in healthy women.
    Anderson MS; Hanley WD; Moreau AR; Jin B; Bieberdorf FA; Kost JT; Wenning LA; Stone JA; Wagner JA; Iwamoto M
    Br J Clin Pharmacol; 2011 Apr; 71(4):616-20. PubMed ID: 21395656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of rimegepant 75 mg daily on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate in healthy female participants.
    Bhardwaj R; Stringfellow JC; Morris B; Croop RS; Bertz RJ
    Headache; 2023 May; 63(5):652-662. PubMed ID: 37140071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
    Hendrix CW; Jackson KA; Whitmore E; Guidos A; Kretzer R; Liss CM; Shah LP; Khoo KC; McLane J; Trapnell CB
    Clin Pharmacol Ther; 2004 May; 75(5):464-75. PubMed ID: 15116059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Potential Drug-Drug Interaction Between Delayed-Release Dimethyl Fumarate and a Commonly Used Oral Contraceptive (Norgestimate/Ethinyl Estradiol) in Healthy Women.
    Zhu B; Nestorov I; Zhao G; Meka V; Leahy M; Kam J; Sheikh SI
    Clin Pharmacol Drug Dev; 2017 Nov; 6(6):604-613. PubMed ID: 28783872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult women.
    Trezza C; Ford SL; Gould E; Lou Y; Huang C; Ritter JM; Buchanan AM; Spreen W; Patel P
    Br J Clin Pharmacol; 2017 Jul; 83(7):1499-1505. PubMed ID: 28087972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic overview of Ortho Evra/Evra.
    Abrams LS; Skee D; Natarajan J; Wong FA
    Fertil Steril; 2002 Feb; 77(2 Suppl 2):S3-12. PubMed ID: 11849630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of saxagliptin on the pharmacokinetics of the active components of Ortho-Cyclen(®), a combined oral contraceptive containing ethinyl estradiol and norgestimate, in healthy women.
    Upreti VV; Hsiang CB; Li L; Xu X; LaCreta FP; Boulton DW
    Diabetes Obes Metab; 2012 Dec; 14(12):1155-7. PubMed ID: 22776778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol/norgestimate.
    Schmitt-Hoffmann AH; Roos B; Sauer J; Schleimer M; Schoetzau A; Leese PT; Weidekamm E; Maares J
    Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():4-11. PubMed ID: 21443598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.
    Kearney BP; Mathias A
    Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.